harveyrhoden07 profile picture
harveyrhoden07 ایک نیا مضمون بنایا
6 d

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP-1 Receptor Agonist Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review. | #aanpak

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP-1 Receptor Agonist Semaglutide (Ozempic) Therapy for D

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP-1 Receptor Agonist Semaglutide (Ozempic) Therapy for D

This systematic literature review evaluates the potential thyroid carcinogenic risk and overall safety profile of semaglutide, a GLP-1 receptor agonist used for the management of diabetes mellitus.

© {تاریخ} GETO Space

زبان